Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic‐reperfusion injury

Acute kidney disease (AKI) leads to increased risk of progression to chronic kidney disease (CKD). Antithrombin III (ATIII) is a potent anticoagulant with anti‐inflammatory properties, and we previously reported that insufficiencies of ATIII exacerbated renal ischaemia‐reperfusion injury (IRI) in ra...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Cell Mol Med
Huvudupphovsmän: Yin, Jianyong, Wang, Feng, Kong, Yiwei, Wu, Rui, Zhang, Guangyuan, Wang, Niansong, Wang, Ling, Lu, Zeyuan, Liang, Mingyu
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2017
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5706518/
https://ncbi.nlm.nih.gov/pubmed/28767184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13261
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk